10x Genomics (TXG) Competitors $11.89 +0.35 (+3.03%) Closing price 04:00 PM EasternExtended Trading$12.08 +0.18 (+1.56%) As of 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock TXG vs. ADPT, PACB, TWST, VCYT, VNT, MIR, CAMT, RAL, ST, and AEHRShould you be buying 10x Genomics stock or one of its competitors? The main competitors of 10x Genomics include Adaptive Biotechnologies (ADPT), Pacific Biosciences of California (PACB), Twist Bioscience (TWST), Veracyte (VCYT), Vontier (VNT), Mirion Technologies (MIR), Camtek (CAMT), Ralliant (RAL), Sensata Technologies (ST), and Aehr Test Systems (AEHR). 10x Genomics vs. Its Competitors Adaptive Biotechnologies Pacific Biosciences of California Twist Bioscience Veracyte Vontier Mirion Technologies Camtek Ralliant Sensata Technologies Aehr Test Systems 10x Genomics (NASDAQ:TXG) and Adaptive Biotechnologies (NASDAQ:ADPT) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their risk, earnings, valuation, media sentiment, analyst recommendations, institutional ownership, profitability and dividends. Do analysts prefer TXG or ADPT? 10x Genomics presently has a consensus price target of $13.65, suggesting a potential upside of 14.83%. Adaptive Biotechnologies has a consensus price target of $14.11, suggesting a potential downside of 17.53%. Given 10x Genomics' higher possible upside, analysts clearly believe 10x Genomics is more favorable than Adaptive Biotechnologies.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score 10x Genomics 2 Sell rating(s) 7 Hold rating(s) 6 Buy rating(s) 1 Strong Buy rating(s) 2.38Adaptive Biotechnologies 1 Sell rating(s) 1 Hold rating(s) 8 Buy rating(s) 0 Strong Buy rating(s) 2.70 Which has stronger valuation & earnings, TXG or ADPT? Adaptive Biotechnologies has lower revenue, but higher earnings than 10x Genomics. Adaptive Biotechnologies is trading at a lower price-to-earnings ratio than 10x Genomics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio10x Genomics$610.78M2.42-$182.63M-$0.70-16.99Adaptive Biotechnologies$178.96M14.56-$159.49M-$0.82-20.87 Do institutionals & insiders hold more shares of TXG or ADPT? 84.7% of 10x Genomics shares are held by institutional investors. Comparatively, 99.2% of Adaptive Biotechnologies shares are held by institutional investors. 10.0% of 10x Genomics shares are held by company insiders. Comparatively, 6.4% of Adaptive Biotechnologies shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. Does the media refer more to TXG or ADPT? In the previous week, 10x Genomics had 2 more articles in the media than Adaptive Biotechnologies. MarketBeat recorded 10 mentions for 10x Genomics and 8 mentions for Adaptive Biotechnologies. 10x Genomics' average media sentiment score of 0.72 beat Adaptive Biotechnologies' score of 0.57 indicating that 10x Genomics is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment 10x Genomics 2 Very Positive mention(s) 3 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Adaptive Biotechnologies 1 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Which has more volatility and risk, TXG or ADPT? 10x Genomics has a beta of 2.05, indicating that its share price is 105% more volatile than the S&P 500. Comparatively, Adaptive Biotechnologies has a beta of 2.06, indicating that its share price is 106% more volatile than the S&P 500. Is TXG or ADPT more profitable? 10x Genomics has a net margin of -13.13% compared to Adaptive Biotechnologies' net margin of -59.07%. 10x Genomics' return on equity of -12.88% beat Adaptive Biotechnologies' return on equity.Company Net Margins Return on Equity Return on Assets 10x Genomics-13.13% -12.88% -10.03% Adaptive Biotechnologies -59.07%-60.93%-23.03% Summary10x Genomics beats Adaptive Biotechnologies on 11 of the 17 factors compared between the two stocks. Get 10x Genomics News Delivered to You Automatically Sign up to receive the latest news and ratings for TXG and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding TXG and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TXG vs. The Competition Export to ExcelMetric10x GenomicsMEDICAL INFO SYS IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.48B$2.35B$6.05B$10.51BDividend YieldN/AN/A5.73%4.80%P/E Ratio-16.9941.4785.4427.36Price / Sales2.4245.96515.26195.91Price / CashN/A61.6637.5761.53Price / Book2.0512.8412.426.82Net Income-$182.63M-$65.79M$3.32B$276.89M7 Day Performance-1.49%0.46%1.01%0.27%1 Month Performance-10.94%15.28%10.75%8.31%1 Year Performance-25.27%41.91%76.20%35.60% 10x Genomics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TXG10x Genomics4.0358 of 5 stars$11.89+3.0%$13.65+14.8%-29.1%$1.48B$610.78M-16.991,240Analyst ForecastADPTAdaptive Biotechnologies2.8294 of 5 stars$14.47+0.6%$13.22-8.6%+214.7%$2.20B$178.96M-17.65790News CoverageAnalyst ForecastGap UpPACBPacific Biosciences of California1.0823 of 5 stars$1.52+2.0%$1.90+25.0%-22.4%$456.56M$154.01M-0.66730News CoverageTWSTTwist Bioscience3.8013 of 5 stars$31.85+2.5%$48.90+53.5%-34.5%$1.92B$312.97M-21.97990Gap UpVCYTVeracyte3.5928 of 5 stars$36.04+0.1%$40.90+13.5%+0.1%$2.84B$445.76M109.22790VNTVontier3.8053 of 5 stars$40.50-2.2%$47.50+17.3%+14.0%$5.94B$2.98B15.408,000MIRMirion Technologies1.7941 of 5 stars$23.17+1.7%$25.67+10.8%+82.7%$5.42B$860.80M772.332,860Positive NewsCAMTCamtek2.3992 of 5 stars$116.68+3.0%$96.10-17.6%+38.1%$5.32B$429.23M42.74400News CoverageAnalyst UpgradeRALRalliant3.4148 of 5 stars$44.05-0.6%$55.13+25.1%N/A$4.97BN/A0.007,000Positive NewsSTSensata Technologies4.6546 of 5 stars$31.05flat$35.91+15.6%-14.9%$4.52B$3.75B41.4019,000AEHRAehr Test Systems1.6742 of 5 stars$31.65+2.0%N/A+74.3%$948.52M$58.97M-243.4490High Trading Volume Related Companies and Tools Related Companies Adaptive Biotechnologies Alternatives Pacific Biosciences of California Alternatives Twist Bioscience Alternatives Veracyte Alternatives Vontier Alternatives Mirion Technologies Alternatives Camtek Alternatives Ralliant Alternatives Sensata Technologies Alternatives Aehr Test Systems Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:TXG) was last updated on 10/15/2025 by MarketBeat.com Staff From Our PartnersURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredBitcoin grabs headlines, but smart money likes this tokenBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | SponsoredGold surges past $3,600 … but this has beat gold by 1,000xGold has surged past $3,600 an ounce — up 45% in the past year — but one veteran metals analyst says the real ...Weiss Ratings | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredArizona-made nanochips the new millionaire maker?George Gilder handed President Reagan the first microchip that helped create $6.5 trillion in wealth over the ...Banyan Hill Publishing | SponsoredBuy UBER immediatelyBULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding 10x Genomics Please log in to your account or sign up in order to add this asset to your watchlist. Share 10x Genomics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
